Nanochon Secures $11.3 Million in Oversubscribed Funding
Washington, D.C., January 12, 2026 — Nanochon, a Washington, D.C.-based orthopedic device company developing next-generation implants for articular cartilage repair, has announced the close of an oversubscribed funding round, bringing its total capital raised to $11.3 million to date. The latest round was led by cultivate(MD), with strong participation from The University of Virginia (UVA) … Read more